BWS
AKBA icon

Buck Wealth Strategies’s Akebia Therapeutics AKBA Stock Holding History

Buck Wealth Strategies’s Portfolio AKBA Stock Details AKBA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.25K Buy
+1,100
New +$1.31K ﹤0.01% 912

Other funds holding AKBA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
CL
Choreo LLC Rockford, Illinois $9.11B AUM 26.3% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Buck Wealth Strategies's AKBA Position: Q2 2026 in Review

Buck Wealth Strategies opened a new position in Akebia Therapeutics (AKBA) in Q2 2026: 1,100 shares worth $1.25K. The stake represents ﹤0.01% of the portfolio and ranks #912 among its holdings.

67 funds tracked by Wall St. Rank hold AKBA as of Q2 2026.

  • Buck Wealth Strategies held 1,100 shares of Akebia Therapeutics worth $1.25K as of Q2 2026.
  • Akebia Therapeutics was a new Buck Wealth Strategies position in Q2 2026.
  • Akebia Therapeutics made up ﹤0.01% of Buck Wealth Strategies's portfolio in Q2 2026, its #912 holding.
  • 67 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q2 2026.

Based on Buck Wealth Strategies's 13F filing for Q2 2026, filed 30 Jul 2026.